Uroplakin gene expression in normal human tissues and locally advanced bladder cancer

被引:105
作者
Olsburgh, J
Harnden, P
Weeks, R
Smith, B
Joyce, A
Hall, G
Poulsom, R
Selby, P
Southgate, J [1 ]
机构
[1] Univ York, Jack Birch Unit Mol Carcinogenesis, York YO10 5YW, N Yorkshire, England
[2] Imperial Canc Res Fund, Ctr Clin, Leeds, W Yorkshire, England
[3] St James Univ Hosp, Dept Urol, Leeds LS9 7TF, W Yorkshire, England
[4] St James Univ Hosp, Dept Pathol, Leeds LS9 7TF, W Yorkshire, England
[5] Imperial Canc Res Fund, Situ Hybridisat Serv, London WC2A 3PX, England
关键词
urothelium; bladder cancer; transitional cell carcinoma; metastasis; differentiation; uroplakin; gene expression; in situ hybridization;
D O I
10.1002/path.1252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The uroplakins are widely regarded as urothelium-specific markers of terminal urothelial cytodifferentiation. This study investigated the expression of the four uroplakin genes, UPIa, UPIb, UPII and UPIII, in a wide range of normal human tissues to determine tissue specificity and in advanced transitional cell carcinoma (TCC) to examine gene expression in primary and metastatic disease. In the urinary tract, all four uroplakins were expressed by urothelium and UPIII was also expressed by prostatic glandular epithelium. UPIa and UPII appeared to be urothelium-specific, but UPIb was detected in several non-urothelial tissues, including the respiratory tract, where it was associated with squamous metaplasia of tracheal and bronchial epithelia. The ten cases of primary TCC and corresponding lymph node metastases demonstrated that each uroplakin gene could be expressed at the mRNA level. No single uroplakin gene was expressed in all primary tumours or metastases, but 80% of the primary tumours and 70% of the lymph node metastases expressed at least one uroplakin gene. UPIII mRNA was often expressed in the absence of UPIII protein. These results confirm that in human tissues the expression of UPIa and UPII genes is highly specific to urothelium and suggest that the tight differentiation-restricted expression of uroplakin genes in normal urothelium is lost following malignant transformation. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 30 条
  • [1] Adachi W, 2000, INVEST OPHTH VIS SCI, V41, P2900
  • [2] Altman D.G., 1991, PRACTICAL STAT MED R, V1st, P403, DOI [10.1002/sim.4780101015, DOI 10.1002/SIM.4780101015]
  • [3] Gazzaniga P, 2001, CLIN CANCER RES, V7, P577
  • [4] Cytokeratin 20 as an objective marker of urothelial dysplasia
    Harnden, P
    Eardley, I
    Joyce, AD
    Southgate, J
    [J]. BRITISH JOURNAL OF UROLOGY, 1996, 78 (06): : 870 - 875
  • [5] Expression of cytokeratin 20 redefines urothelial papillomas of the bladder
    Harnden, P
    Mahmood, N
    Southgate, J
    [J]. LANCET, 1999, 353 (9157) : 974 - 977
  • [6] HODGES GM, 1979, BIOMEDICAL RES APPL, P307
  • [7] Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux
    Hu, P
    Deng, FM
    Liang, FX
    Hu, CM
    Auerbach, AB
    Shapiro, E
    Wu, XR
    Kachar, B
    Sun, TT
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 151 (05) : 961 - 971
  • [8] Jiang JZ, 2001, ARCH PATHOL LAB MED, V125, P921
  • [9] CLONING OF A GROWTH ARREST-SPECIFIC AND TRANSFORMING GROWTH-FACTOR BETA-REGULATED GENE, TI-1, FROM AN EPITHELIAL-CELL LINE
    KALLIN, B
    DEMARTIN, R
    ETZOLD, T
    SORRENTINO, V
    PHILIPSON, L
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (10) : 5338 - 5345
  • [10] Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas
    Kaufmann, O
    Volmerig, J
    Dietel, M
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (05) : 683 - 687